Corcept Therapeutics (CORT) Cash from Financing Activities (2010 - 2026)
Corcept Therapeutics recorded quarterly Cash from Financing Activities of $760000.0 in Q1 2026, up 102.43% quarter-over-quarter from -$31.2 million in Q4 2025, and up 101.91% year-over-year from $376406.4 in Q1 2025.
Corcept Therapeutics' Cash from Financing Activities history runs 17 years deep, the most recent figure standing at $760000.0 for Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 101.91% year-over-year to $760000.0; the TTM figure through Mar 2026 stood at -$179.8 million (down 165.95% YoY), while the FY2025 annual figure was -$220.4 million, down 677.33% from the prior year.
- Cash from Financing Activities came in at $760000.0 for Q1 2026 at Corcept Therapeutics, up from -$31.2 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $766000.0 in Q4 2023 to a low of -$145.8 million in Q2 2023.
- A 5-year average of -$24.4 million and a median of -$3.9 million in 2023 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities soared 1355.74% in 2023 and tumbled 7230.2% in 2025, its largest moves.
- Corcept Therapeutics' Cash from Financing Activities stood at -$61000.0 in 2022, then jumped by 1355.74% to $766000.0 in 2023, then tumbled by 695.82% to -$4.6 million in 2024, then sank by 583.96% to -$31.2 million in 2025, then soared by 102.43% to $760000.0 in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $760000.0, -$31.2 million, and -$46.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -802.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 15.71 Mn |
| 10 | Corcept Therapeutics | 7.26 Bn | 6.92 Bn | 162.02 Mn | 760,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 760,000.00 |
| Mar 31, 2026 | 760,000.00 |
| Dec 31, 2025 | -31.22 Mn |
| Dec 31, 2025 | -31.22 Mn |
| Sep 30, 2025 | -46.41 Mn |
| Sep 30, 2025 | -46.41 Mn |
| Jun 30, 2025 | -102.93 Mn |
| Jun 30, 2025 | -102.93 Mn |
| Mar 31, 2025 | -39.80 Mn |
| Mar 31, 2025 | -39.80 Mn |
| Dec 31, 2024 | -4.56 Mn |
| Dec 31, 2024 | -4.56 Mn |
| Sep 30, 2024 | -21.09 Mn |
| Sep 30, 2024 | -21.09 Mn |
| Jun 30, 2024 | -2.15 Mn |
| Jun 30, 2024 | -2.15 Mn |
| Mar 31, 2024 | -543,000.00 |
| Mar 31, 2024 | -543,000.00 |
| Dec 31, 2023 | 766,000.00 |
| Dec 31, 2023 | 766,000.00 |
| Sep 30, 2023 | -3.92 Mn |
| Sep 30, 2023 | -3.92 Mn |
| Jun 30, 2023 | -145.75 Mn |
| Jun 30, 2023 | -145.75 Mn |
| Mar 31, 2023 | 181,000.00 |
| Mar 31, 2023 | 181,000.00 |
| Dec 31, 2022 | -61,000.00 |
| Dec 31, 2022 | -61,000.00 |
| Sep 30, 2022 | -13.96 Mn |
| Sep 30, 2022 | -13.96 Mn |
| Jun 30, 2022 | -2.76 Mn |
| Jun 30, 2022 | -2.76 Mn |
| Mar 31, 2022 | -506,000.00 |
| Mar 31, 2022 | -506,000.00 |
| Dec 31, 2021 | -206.97 Mn |
| Dec 31, 2021 | -206.97 Mn |
| Sep 30, 2021 | -23.64 Mn |
| Sep 30, 2021 | -23.64 Mn |
| Jun 30, 2021 | -26.03 Mn |
| Jun 30, 2021 | -26.03 Mn |
| Mar 31, 2021 | -45.95 Mn |
| Mar 31, 2021 | -45.95 Mn |
| Dec 31, 2020 | -661,000.00 |
| Dec 31, 2020 | -661,000.00 |
| Sep 30, 2020 | 5.87 Mn |
| Sep 30, 2020 | 5.87 Mn |
| Jun 30, 2020 | 6.80 Mn |
| Jun 30, 2020 | 6.80 Mn |
| Mar 31, 2020 | 205,000.00 |
| Mar 31, 2020 | 205,000.00 |
| Dec 31, 2019 | -144,000.00 |
| Dec 31, 2019 | -144,000.00 |
| Sep 30, 2019 | 2.70 Mn |
| Sep 30, 2019 | 2.70 Mn |
| Jun 30, 2019 | -15.91 Mn |
| Jun 30, 2019 | -15.91 Mn |
| Mar 31, 2019 | -15.29 Mn |
| Mar 31, 2019 | -15.29 Mn |
| Dec 31, 2018 | -12.03 Mn |
| Dec 31, 2018 | -12.03 Mn |
| Sep 30, 2018 | -8.27 Mn |
| Sep 30, 2018 | -8.27 Mn |
| Jun 30, 2018 | 4.04 Mn |
| Jun 30, 2018 | 4.04 Mn |
| Mar 31, 2018 | 1.92 Mn |
| Mar 31, 2018 | 1.92 Mn |
| Dec 31, 2017 | 2.57 Mn |
| Dec 31, 2017 | 2.57 Mn |
| Sep 30, 2017 | -1.84 Mn |
| Sep 30, 2017 | -1.84 Mn |
| Jun 30, 2017 | -4.97 Mn |
| Jun 30, 2017 | -4.97 Mn |
| Mar 31, 2017 | -3.71 Mn |
| Mar 31, 2017 | -3.71 Mn |
| Dec 31, 2016 | -823,000.00 |
| Dec 31, 2016 | -823,000.00 |
| Sep 30, 2016 | -2.77 Mn |
| Sep 30, 2016 | -2.77 Mn |
| Jun 30, 2016 | -538,000.00 |
| Jun 30, 2016 | -538,000.00 |
| Mar 31, 2016 | -2.97 Mn |
| Mar 31, 2016 | -2.97 Mn |
| Dec 31, 2015 | -195,000.00 |
| Dec 31, 2015 | -195,000.00 |
| Sep 30, 2015 | -1.48 Mn |
| Sep 30, 2015 | -1.48 Mn |
| Jun 30, 2015 | -766,000.00 |
| Jun 30, 2015 | -766,000.00 |
| Mar 31, 2015 | 15.52 Mn |
| Mar 31, 2015 | 15.52 Mn |
| Dec 31, 2014 | -1.13 Mn |
| Dec 31, 2014 | -1.13 Mn |
| Sep 30, 2014 | -1.25 Mn |
| Sep 30, 2014 | -1.25 Mn |
| Jun 30, 2014 | -612,000.00 |
| Jun 30, 2014 | -612,000.00 |
| Mar 31, 2014 | -89,000.00 |
| Mar 31, 2014 | -89,000.00 |
| Dec 31, 2013 | -592,000.00 |
| Dec 31, 2013 | -592,000.00 |
| Dec 31, 2012 | 204,000.00 |
| Dec 31, 2012 | 204,000.00 |
| Sep 30, 2012 | 76.01 Mn |
| Sep 30, 2012 | 76.01 Mn |
| Jun 30, 2012 | 198,000.00 |
| Jun 30, 2012 | 198,000.00 |
| Mar 31, 2012 | 13.16 Mn |
| Mar 31, 2012 | 13.16 Mn |
| Dec 31, 2011 | 45,000.00 |
| Dec 31, 2011 | 45,000.00 |
| Sep 30, 2011 | 283,000.00 |
| Sep 30, 2011 | 283,000.00 |
| Jun 30, 2011 | 236,000.00 |
| Jun 30, 2011 | 236,000.00 |
| Mar 31, 2011 | 41.92 Mn |
| Mar 31, 2011 | 41.92 Mn |
| Dec 31, 2010 | 1.06 Mn |
| Dec 31, 2010 | 1.06 Mn |
| Sep 30, 2010 | 17,000.00 |
| Sep 30, 2010 | 17,000.00 |